EClinicalMedicine (Feb 2024)

Factors associated with viral load non-suppression among treatment-experienced pre-teenage children living with HIV in Kenya: a nationwide population-based cohort study, 2015–2021Research in context

  • Martin M. Mulinge,
  • Nancy K. Kibui,
  • Humphrey Kimani,
  • Joseph Wainaina,
  • Priska Bwana,
  • Martin Omondi,
  • Kevin Wafula,
  • Dalton C. Wamalwa,
  • Evans O. Omondi,
  • Ruth W. Nduati,
  • Matilu Mwau

Journal volume & issue
Vol. 68
p. 102454

Abstract

Read online

Summary: Background: Viral load non-suppression (VLNS) in children is a major public health concern because of attendant HIV disease progression and risk of morbidity and mortality. Based on a nationally representative database we present estimates of the prevalence, trends and factors associated with VLNS in Kenyan pre-teenage children between 2015 and 2021. Methods: Kenya National AIDS & STI Control Program's (NASCOP) maintains an early infant diagnosis and viral load (EID/VL) database for all persons living with HIV who are enrolled in the country's primary care clinics for purposes of monitoring progress towards achievement of the 95% viral suppression goals. Participants were eligible if they were children living with HIV (CLHIV), on combination ART (cART) treatment, and ≤12 years old. The modified Mann–Kendall trend test for serially correlated data was used to identify VLNS trends. Generalized estimating equations (GEE) with a logit link was used to assess the effects of covariates on the odds of VLNS (VL ≥1,000 copies/mL) over repeated points in time, allowing for the correlation among the repeated measures. Findings: Between January 2015 and December 2021, 508,743 viral load tests were performed on samples collected from 109,682 pre-teenage children. The prevalence of VLNS decreased from 22.9% (95% CI 22.4–23.3) to 12.5% (95% CI 12.1–12.9), p < 0.0001, and mean age increased from 3.1 (4.2) to 8.0 (3.2) years in 2015 and 2021 respectively. A modified Mann–Kendall trend test for serially correlated data denotes a statistically significant decreasing trend (τ = −0.300, p < 0.0001) over the study period. In the multivariable GEE analysis adjusted for covariates, the odds of VLNS decreased by 11% per year during the study period, (GEE-aOR 0.89, 95% CI 0.88–0.90; p < 0.0001). Factors positively associated with VLNS were EFV/NVP-based first-line cART regimen (GEE-aOR 1.74, 95% CI 1.65–1.84, p < 0.0001), PI-based cART regimen (GEE-aOR 1.82, 95% CI 1.72–1.92, p < 0.0001), and children aged 1–3 years (toddlers) (GEE-aOR: 1.84, 95% CI 1.79–1.90, p < 0.0001). On the contrary, DTG-based cART regimen, were negatively associated with VLNS (GEE-aOR 0.70, 95% CI 0.65–0.75, p < 0.0001). Interpretation: There is a strong evidence of decreasing viremia between 2015 and 2021. To sustain the decreasing trend, accelerating the switch from the suboptimal EVP/NVP first-line regimen to optimised DTG regimen is warranted. Funding: U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and Clinton Health Access Initiative (CHAI).

Keywords